1. Yajima, Hiroshi, Kawakami, Kiyoshi. 2016. Low Six4 and Six5 gene dosage improves dystrophic phenotype and prolongs life span of mdx mice. In Development, growth & differentiation, 58, 546-61. doi:10.1111/dgd.12290. https://pubmed.ncbi.nlm.nih.gov/27224259/
2. Wang, Junzheng, Liu, Manling, Zhao, Lihua, Dai, Yifan, Li, Rongfeng. 2019. Disabling of nephrogenesis in porcine embryos via CRISPR/Cas9-mediated SIX1 and SIX4 gene targeting. In Xenotransplantation, 26, e12484. doi:10.1111/xen.12484. https://pubmed.ncbi.nlm.nih.gov/30623494/
3. He, Qin, Lin, Zhuoying, Wang, Zhihui, Liu, Mei, Xia, Limin. 2020. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET. In Oncogene, 39, 7279-7295. doi:10.1038/s41388-020-01500-y. https://pubmed.ncbi.nlm.nih.gov/33046796/
4. Heiat, Mohammad, Rezaei, Ehsan, Gharechahi, Javad, Abyazi, Mohammad Ali, Baradaran, Behzad. 2023. Knockdown of SIX4 inhibits pancreatic cancer cells via apoptosis induction. In Medical oncology (Northwood, London, England), 40, 287. doi:10.1007/s12032-023-02163-x. https://pubmed.ncbi.nlm.nih.gov/37656231/
5. Liang, Beiyuan, Zhang, Evan H, Ye, Zhen, Miles, Wayne, Wang, Jing J. . SIX4 Controls Anti-PD-1 Efficacy by Regulating STING Expression. In Cancer research communications, 3, 2412-2419. doi:10.1158/2767-9764.CRC-23-0265. https://pubmed.ncbi.nlm.nih.gov/37888903/
6. Sun, Xuling, Hu, Fuqing, Hou, Zhenlin, Hu, Junbo, Cao, Zhixin. 2019. SIX4 activates Akt and promotes tumor angiogenesis. In Experimental cell research, 383, 111495. doi:10.1016/j.yexcr.2019.111495. https://pubmed.ncbi.nlm.nih.gov/31301290/
7. Wu, Hua-Tao, Wu, Zheng, Hou, Yan-Yu, Cui, Yu-Kun, Liu, Jing. 2023. SIX4, a potential therapeutic target for estrogen receptor-positive breast cancer patients, is associated with low promoter methylation level. In Epigenomics, 15, 911-925. doi:10.2217/epi-2023-0232. https://pubmed.ncbi.nlm.nih.gov/37905439/
8. Li, Bing, Dang, Xiaoqian, Duan, Jiafeng, Zhang, Jia, Song, Qichun. 2023. SIX4 upregulates IDH1 and metabolic reprogramming to promote osteosarcoma progression. In Journal of cellular and molecular medicine, 27, 259-265. doi:10.1111/jcmm.17650. https://pubmed.ncbi.nlm.nih.gov/36601689/
9. Han, Jinbiao, Hu, Xia. 2022. IGF2BP3‑stabilized SIX4 promotes the proliferation, migration, invasion and tube formation of ovarian cancer cells. In Molecular medicine reports, 26, . doi:10.3892/mmr.2022.12748. https://pubmed.ncbi.nlm.nih.gov/35616130/
智鼠故事 
